Moderna halted its Phase 1 trial of an mRNA vaccine to treat the Epstein-Barr virus after a single suspected case of myocarditis in an adolescent, raising questions about the heart-damaging technology used in all mRNA vaccines, according to a report by Alex Berenson.
DETAILS ⬇️
https://childrenshealthdefense.org/defender/moderna-vaccine-epstein-barr-virus-myocarditis-risk/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20231120
Moderna halted its Phase 1 trial of an mRNA vaccine to treat the Epstein-Barr virus after a single suspected case of myocarditis in an adolescent, raising questions about the heart-damaging technology used in all mRNA vaccines, according to a report by Alex Berenson.
childrenshealthdefense.org
0
Share on Telegram
Share on Facebook
Share on Twitter
Share on Reddit